COHR vs CLS vs GRMN
161 measures in 16 categories, one definition each, computed from filings and market data.
COHR42.8
Coherent, Inc.
Technology · Hardware, Equipment & Parts
$232.90 −7.06%$45.9B mkt cap
Score DNA
CLS65.8
Celestica Inc.
Technology · Hardware, Equipment & Parts
$303.81 −3.63%$38.3B mkt cap
Score DNA
GRMN77.9
Garmin Ltd.
Technology · Hardware, Equipment & Parts
$284.79 −0.18%$54.9B mkt cap
Score DNA
Price, rebased to 100 three years ago
COHR CLS GRMN · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 3 | 0 | 0 |
| Last Congress purchase | 2026-09-25 | — | — |
| 13F net change in holders | — | +101 | −6 |
| ETFs adding shares, 30d | 1,212 | 34 | 1,207 |
| ETFs trimming, 30d | 927 | 20 | 846 |
| Net ETF funds, 30d | +285 | +14 | +361 |
Valuation
16 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| P/E (TTM) | 57.0x
82nd
|
34.3x
45th
|
29.3x
27th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | 0.38
5th
|
1.26
35th
|
| Price / sales | 6.4x
78th
|
2.5x
30th
|
7.2x
85th
|
| Price / book | 4.2x
65th
|
15.5x
98th
|
6.1x
82nd
|
| Price / tangible book | 21.9x
84th
|
22.3x
87th
|
5.6x
29th
|
| Price / free cash flow | — | 73.7x
91st
|
35.8x
72nd
|
| Price / operating cash flow | 576.8x
100th
|
33.4x
76th
|
28.7x
57th
|
| Enterprise value | $47.4B
90th
|
$38.6B
88th
|
$52.4B
92nd
|
| EV / sales | 6.7x
82nd
|
2.5x
32nd
|
6.8x
85th
|
| EV / EBITDA | 30.4x
83rd
|
24.9x
72nd
|
21.3x
61st
|
| EV / EBIT | 45.7x
83rd
|
28.1x
58th
|
23.1x
33rd
|
| EV / free cash flow | — | 74.2x
91st
|
34.2x
69th
|
| Earnings yield | 1.8%
32nd
|
2.9%
62nd
|
3.4%
78th
|
| FCF yield | -2.2%
10th
|
1.4%
28th
|
2.8%
42nd
|
| Operating cash flow yield | 0.2%
8th
|
3.0%
30th
|
3.5%
48th
|
| Graham number (per share) | $69.50
64th
|
$67.95
61st
|
$100.94
91st
|
Profitability (TTM)
12 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| Gross margin | 37.5%
42nd
|
12.0%
15th
|
60.1%
88th
|
| EBITDA margin | 21.9%
70th
|
9.9%
32nd
|
32.1%
98th
|
| Operating margin | 12.0%
45th
|
8.1%
30th
|
27.6%
98th
|
| EBIT margin | 14.6%
62nd
|
8.8%
38th
|
29.6%
98th
|
| Net margin | 11.3%
70th
|
7.2%
48th
|
24.5%
95th
|
| NOPAT margin | 11.1%
52nd
|
6.9%
32nd
|
22.8%
95th
|
| FCF margin | -14.5%
8th
|
3.3%
22nd
|
20.0%
90th
|
| Operating cash flow margin | 1.1%
12th
|
7.3%
32nd
|
24.9%
95th
|
| R&D / revenue | 10.2%
82nd
|
1.0%
31st
|
15.4%
90th
|
| SG&A / revenue | 14.7%
33rd
|
1.8%
0th
|
17.1%
49th
|
| Stock comp / revenue | 2.6%
74th
|
0.4%
5th
|
1.7%
56th
|
| Effective tax rate | 7.2%
3rd
|
14.8%
28th
|
17.3%
38th
|
Returns on capital
11 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| ROE (on average equity) | 8.5%
35th
|
52.7%
98th
|
21.9%
90th
|
| ROA | 4.8%
42nd
|
13.9%
90th
|
17.3%
98th
|
| ROIC | 6.3%
22nd
|
39.3%
100th
|
26.8%
90th
|
| ROCE | 6.7%
28th
|
38.1%
100th
|
24.3%
95th
|
| Return on tangible assets | 6.3%
32nd
|
17.1%
95th
|
20.9%
98th
|
| Cash ROIC (OCF / invested capital) | 0.6%
10th
|
41.6%
98th
|
29.3%
90th
|
| Gross profitability (GP / assets) | 14.6%
22nd
|
18.5%
40th
|
40.3%
100th
|
| ROIC, 3-yr average | 1.6%
11th
|
25.6%
91st
|
25.2%
89th
|
| ROIC, 5-yr average | 1.4%
14th
|
20.2%
72nd
|
29.0%
86th
|
| ROE, 5-yr average | 1.5%
11th
|
22.5%
92nd
|
18.7%
86th
|
| Incremental ROIC | 30.7%
74th
|
96.6%
95th
|
48.7%
77th
|
Growth
17 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| Revenue growth (TTM YoY) | 22.5%
64th
|
47.5%
85th
|
13.5%
41st
|
| Revenue growth (QoQ) | 13.3%
70th
|
16.1%
80th
|
15.3%
75th
|
| Revenue CAGR, 3 yr | 11.3%
76th
|
26.3%
92nd
|
16.0%
86th
|
| Revenue CAGR, 5 yr | 18.0%
92nd
|
22.8%
97th
|
9.6%
67th
|
| Gross profit CAGR, 3 yr | 18.0%
89th
|
37.1%
97th
|
17.7%
86th
|
| Operating income CAGR, 3 yr | 74.9%
97th
|
60.4%
94th
|
28.9%
79th
|
| Net income growth (TTM YoY) | 1,530.7%
100th
|
113.3%
70th
|
19.7%
47th
|
| Net income CAGR, 3 yr | — | 88.0%
97th
|
23.6%
72nd
|
| EPS growth (TTM YoY) | 1,154.1%
100th
|
112.8%
73rd
|
19.7%
50th
|
| EPS CAGR, 3 yr | — | 90.1%
97th
|
23.2%
76th
|
| EPS CAGR, 5 yr | 9.2%
45th
|
69.7%
97th
|
9.6%
48th
|
| FCF growth (TTM YoY) | — | 53.1%
75th
|
36.2%
56th
|
| FCF CAGR, 3 yr | — | 29.0%
70th
|
21.0%
63rd
|
| Operating cash flow CAGR, 3 yr | -49.9%
6th
|
44.7%
91st
|
21.2%
68th
|
| Book value CAGR, 3 yr | 1.3%
22nd
|
15.2%
81st
|
13.4%
78th
|
| Dividend CAGR, 3 yr | -11.7%
22nd
|
— | 5.7%
94th
|
| Sustainable growth rate | 8.3%
30th
|
52.7%
97th
|
13.5%
58th
|
Margin history & stability
7 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| Gross margin, 3-yr average | 34.6%
45th
|
11.1%
13th
|
58.9%
87th
|
| Operating margin, 3-yr average | 8.0%
39th
|
6.9%
34th
|
25.3%
97th
|
| Net margin, 3-yr average | 2.9%
29th
|
5.4%
45th
|
24.0%
97th
|
| FCF margin, 3-yr average | -2.3%
8th
|
3.3%
18th
|
20.2%
92nd
|
| Revenue stability (0-1) | 0.90
89th
|
0.86
82nd
|
0.83
79th
|
| Earnings stability (0-1) | 0.09
24th
|
0.80
87th
|
0.73
82nd
|
| Margin stability (0-1) | 0.90
24th
|
0.86
13th
|
0.98
100th
|
Liquidity (latest quarter)
7 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| Cash & short-term investments | $2.0B
88th
|
$535.7M
62nd
|
$2.7B
95th
|
| Net cash (− = net debt) | −$1.6B
22nd
|
−$274.7M
38th
|
$2.5B
100th
|
| Working capital | $4.1B
90th
|
$1.4B
75th
|
$4.2B
92nd
|
| Current ratio | 2.43
55th
|
1.23
8th
|
3.03
65th
|
| Quick ratio | 1.52
38th
|
0.68
2nd
|
2.08
62nd
|
| Cash ratio (cash + ST investments / current liabilities) | 0.70
52nd
|
0.09
2nd
|
1.28
65th
|
| Defensive interval (days) | 669 days
40th
|
2,615 days
92nd
|
560 days
32nd
|
Leverage & solvency (latest quarter)
13 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| Total debt | $3.5B
88th
|
$810.4M
57th
|
$178.0M
40th
|
| Debt / equity | 0.32
60th
|
0.33
62nd
|
0.02
12th
|
| Net debt / equity | 0.14
62nd
|
0.11
57th
|
−0.28
22nd
|
| Debt / assets | 19.3%
65th
|
8.3%
35th
|
1.6%
12th
|
| Debt / capital | 24.5%
60th
|
24.6%
62nd
|
1.9%
12th
|
| Debt / EBITDA | 2.27
64th
|
0.52
31st
|
0.07
8th
|
| Net debt / EBITDA | 0.99
64th
|
0.18
50th
|
−1.01
33rd
|
| Interest coverage (EBIT / interest) | 5.5x
32nd
|
21.9x
88th
|
— |
| Cash interest coverage | 0.4x
9th
|
18.3x
88th
|
— |
| Debt payback (years of OCF) | 44.5 yrs
97th
|
0.7 yrs
30th
|
0.1 yrs
8th
|
| Liabilities / assets | 38.6%
48th
|
74.7%
95th
|
21.0%
18th
|
| IS credit model rating | A | AA+ | AA+ |
| Implied credit spread (bps) | 150
57th
|
65
0th
|
65
0th
|
Efficiency
11 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| Asset turnover | 0.43
15th
|
1.95
100th
|
0.71
62nd
|
| Fixed asset turnover | 0.33
2nd
|
13.24
82nd
|
4.60
30th
|
| Inventory turnover | 2.2
10th
|
5.2
87th
|
1.6
3rd
|
| Receivables turnover | 6.2
60th
|
5.6
38th
|
7.1
90th
|
| Days sales outstanding | 59 days
40th
|
66 days
62nd
|
51 days
10th
|
| Days inventory outstanding | 165 days
90th
|
70 days
13th
|
224 days
97th
|
| Days payables outstanding | 113 days
95th
|
72 days
70th
|
48 days
22nd
|
| Cash conversion cycle (days) | 111 days
52nd
|
64 days
15th
|
228 days
95th
|
| Capex / revenue | 15.6%
97th
|
4.0%
64th
|
4.9%
69th
|
| Capex / depreciation | 2.13
90th
|
3.54
95th
|
1.96
87th
|
| Operating expense ratio | 26.1%
52nd
|
2.5%
2nd
|
32.0%
68th
|
Cash flow & earnings quality
7 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| Operating cash flow / net income | 0.10
0th
|
1.03
21st
|
1.02
18th
|
| FCF / net income | −1.28
3rd
|
0.47
21st
|
0.82
27th
|
| FCF / operating cash flow | -1,296.1%
0th
|
45.4%
19th
|
80.2%
50th
|
| Capex / operating cash flow | 1,396.1%
100th
|
54.6%
81st
|
19.8%
50th
|
| Accruals ratio | 4.4%
92nd
|
-0.4%
80th
|
-0.3%
82nd
|
| Sloan accruals ratio | 8.5%
75th
|
-2.9%
22nd
|
1.3%
50th
|
| Earnings quality score (0-1) | 0.25
0th
|
1.00
36th
|
1.00
36th
|
Scores & forensic checks
15 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| IS score | 43
10th
|
66
72nd
|
78
98th
|
| IS profitability | 40
45th
|
50
68th
|
92
100th
|
| IS growth | 74
77th
|
82
97th
|
65
46th
|
| IS value | 39
50th
|
25
5th
|
58
90th
|
| IS momentum | 62
23rd
|
93
72nd
|
83
51st
|
| IS risk (safety) | 100
28th
|
100
28th
|
100
28th
|
| IS quality | 52
15th
|
71
52nd
|
88
95th
|
| IS balance sheet | 72
48th
|
68
35th
|
98
100th
|
| IS earnings quality | 40
8th
|
72
55th
|
78
100th
|
| IS cash flow | 2
0th
|
55
40th
|
80
90th
|
| Piotroski F-score (0-9) | 7
60th
|
6
22nd
|
7
60th
|
| Altman Z-score | 7.7
55th
|
5.8
42nd
|
13.9
90th
|
| Beneish M-score | −2.73
23rd
|
−1.95
85th
|
−2.35
62nd
|
| Ohlson O-score | −9.48
28th
|
−7.07
82nd
|
−11.88
5th
|
| IS credit score | 72
32nd
|
94
92nd
|
92
75th
|
Size (TTM)
8 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| Market cap | $45.9B
90th
|
$38.3B
88th
|
$54.9B
92nd
|
| Revenue | $7.1B
82nd
|
$15.6B
90th
|
$7.7B
85th
|
| EBITDA | $1.6B
82nd
|
$1.6B
80th
|
$2.5B
95th
|
| Net income | $805.0M
80th
|
$1.1B
90th
|
$1.9B
95th
|
| Free cash flow | −$1.0B
0th
|
$519.9M
72nd
|
$1.5B
92nd
|
| Total assets | $18.3B
90th
|
$9.8B
78th
|
$11.4B
80th
|
| Shareholders' equity | $10.9B
92nd
|
$2.5B
68th
|
$9.0B
90th
|
| Employees | 51,478
90th
|
23,803
85th
|
23,000
82nd
|
Price performance
9 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| 1 day | −7.1% | −3.6% | −0.2% |
| 1 week | −25.5% | −16.1% | +6.1% |
| 1 month | −21.3% | −7.9% | +3.4% |
| 3 months | −18.4% | −1.1% | +16.3% |
| 6 months | −32.5% | −23.3% | +6.5% |
| Year to date | +19.9% | +0.5% | +40.6% |
| 1 year | +110.9% | +12.5% | +14.6% |
| 3 years, cumulative | +569.5% | +1,046.5% | +172.3% |
| 5 years, cumulative | +307.1% | +3,156.3% | +101.4% |
Technicals
4 measures| Measure | COHR | CLS | GRMN |
|---|---|---|---|
| RSI 14 | 33.4 | 36.7 | 54.4 |
| From 52-week high | −47.1% | −35.9% | −9.4% |
| From 52-week low | +107.3% | +24.2% | +53.2% |
| Beta | 2.11 | 1.46 | 0.83 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17